Jeevan Scientific Technology Ltd Valuation
JSTL · Healthcare · Current price ₹71.53
Is Jeevan Scientific Technology Ltd undervalued?
DocStoX estimates the fair value of Jeevan Scientific Technology Ltd at ₹30 per share, versus the current market price of ₹72. That puts the stock about -58.1% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 1 independent method: Residual income (₹30). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹26 (bear) to ₹30 (base) to ₹35 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Valuation multiples
Jeevan Scientific Technology Ltd trades at a P/E of 894.1x and a P/B of 2.0x, with a dividend yield of 1.7%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on Jeevan Scientific Technology Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.